TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal February 3, 1995